Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV

Zeng Q. -L.; Li C. -X.; Zhang D. -W.; Li W.; Xu G. -H.; Yu Z. -J.

首页> 外文期刊>Alimentary pharmacology & therapeutics. >Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV

【24h】

Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV

机译：信：索非布韦联合达卡他韦联合利巴韦林在中国治疗经验丰富的肝硬化基因型1b HCV患者中安全性和有效性12周

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Alimentary pharmacology & therapeutics.》 |2016年第7期|共2页
作者
Zeng Q. -L.; Li C. -X.; Zhang D. -W.; Li W.; Xu G. -H.; Yu Z. -J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV [J] . Zeng Q. -L., Li C. -X., Zhang D. -W., Alimentary pharmacology & therapeutics. . 2016,第7期

机译：信：索非布韦联合达卡他韦联合利巴韦林在中国治疗经验丰富的肝硬化基因型1b HCV患者中安全性和有效性12周
2. P1‐092: The efficacy of sofosbuvir/velpatasvir/ribavirin in cirrhotic, genotype 3a HCV patients, previously failures to sofosbuvir/daclatasvir/ribavirin combination [J] . Journal of viral hepatitis. . 2018,第S1期

机译：P1-092：Sofosbuvir / VelpataSvir /利巴韦林在肝硬化，基因型3A HCV患者中的疗效，以前对Sofosbuvir / daclatasvir /利巴韦林组合的故障
3. Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients [J] . Ji Dong, Chen Guo-Feng, Wang Cheng, Hepatology international . 2016,第5期

机译：十二周无利巴韦林的直接作用抗病毒药治疗经验丰富的中国人，患有HCV基因型1b感染，包括肝硬化患者
4. Efficacy of combination therapy of interferon-α and ribavirin for HIV/HCV co-infected patients in a six-year follow-up [C] . AiPing Wang, ChunYang Wen, Fang Gao 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：六年随访中干扰素-α和利巴韦林联合治疗对HIV / HCV合并感染患者的疗效
5. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
6. High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients [O] . Adriano Pellicelli, Vincenzo Messina, Valerio Giannelli, 2020

机译：平剂量利巴韦林加Sofosbuvir / Daclatasvir在基因型3肝硬化患者中的高疗效和安全性
7. Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12 weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV [O] . Q.-L. Zeng, C.-X. Li, D.-W. Zhang, 2016

机译：字母：Sofosbuvir Plus daclatasvir与利巴韦林的安全性和疗效在中药治疗中的12周龄肝硬化基因型1B患者HCV患者

Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV

著录项

引文网络

相似文献

相关主题

期刊订阅